fashion -WSS

fashion

author：Wikipedia 2025-10-01 01:50:14 - browse：78

Exterior photo of UnitedHealth Group building — UnitedHealth Group is attempting to buy Amedisys for $3.3 billion. Courtesy UnitedHealth Group

There’s now a two-party showdown for one of the largest home health companies in the country.

UnitedHealth Group and its Optum division on Monday formally proposed to buy Amedisys for $100 per share, or about $3.3 billion.

The offer comes a few weeks after Option Care Health proposed a $3.6 billion takeover. However, Option Care’s deal is an all-stock transaction, whereas UnitedHealth would pay all cash — a potentially more attractive offer for Amedisys shareholders who want a more immediate payout that isn’t tied to the unpredictability of another company’s stock price. Option Care’s offer is technically worth closer to $2.8 billion now, due to the drop in Option Care’s stock price since the merger was announced. Amedisys is recommending shareholders vote in favor of the deal with Option Care.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Cancer drug shortages should be causing more outrage
Next article： Humana’s Medicare Advantage lawsuit should be tossed, DOJ says

hotspot

WSS

Virtual care provider acquires bankrupt Pear's prescription apps

Advocates call out 'SNL' over stereotypes, errors in sickle cell skit

Biden White House, tech companies launch new safeguards around emerging AI technology

How to keep neuroscience’s past racism from being its future

Keeping primary care docs in field isn't impossible, says AAFP CEO

Carvykti CAR

focus

fashion

explore

Activists slam private health insurers over coverage restrictions

Florida babysitter arrested over hot car death, authorities say

Anesthesiologist group: stop taking Ozempic before surgery

Listen: BridgeBio's big week & Lilly's Alzheimer's data

In Memoriam: Notable people who died in 2023

Why health care costs have stayed mostly flat since 2010

As demand for Covid shots wanes, Moderna seeks its next success

Biden, Billy Joel, Elton John lead tributes for Tony Bennett after singer's death at 96

In Memoriam: Notable people who died in 2023

SNAP should offer more nutrition education

focus

Bristol Myers buys into radiopharmaceuticals with RayzeBio

SEC charges former device maker CEO with $41 million fraud

Family of Gilgo Beach murder suspect releases statement: 'Devastating time'

What STAT readers think about the FDA and patient advocacy

New chief aims to remake Sanofi Genzyme

What is artificial intelligence? Experts weigh in

leisure time

focus

hotspot

hotspot